SCHEMBL29484012

SCHEMBL29484012

CN1CCOc2cc(F)ccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
HTT P42858 1/20 0.59
RECQL P46063 1/20 0.59
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
NOTUM Q6P988 1/20 0.48
AR P10275 1/20 0.45
PTGES2 Q9H7Z7 1/20 0.42
NPC1 O15118 1/20 0.42
PKM P14618 1/20 0.42
PKLR P30613 1/20 0.42
RAB9A P51151 1/20 0.42
HDAC4 P56524 2/20 0.41
PDE10A Q9Y233 1/20 0.41
RORC P51449 1/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2616332 1.00 ALDH1A1 (0.59) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL20348516 0.87 ALDH1A1 (0.50) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL154510 0.80 CYP11B1 (0.52) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL2334976 0.80 CYP11B1 (0.52) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL10623849 0.79 AR (0.46) ALDH1A1HTTRECQLARPIK3CD
SCHEMBL25443617 0.79 CYP11B1 (0.51) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL6793277 0.79 CYP11B1 (0.51) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL902429 0.79 CYP11B1 (0.51) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL21893788 0.79 CYP11B1 (0.51) ALDH1A1HTTRECQLCYP11B1CYP11B2
SCHEMBL12461862 0.79 CYP11B1 (0.51) ALDH1A1HTTRECQLCYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022056252-A1 COMPOSITIONS AND METHODS FOR TREATING HYPERGLYCEMIA IN TYPE-2 DIABETES THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) 2022-03-17 WO disclosed